Clinical Trial

Study of Novel Therapies for Young People With Recurrent/Progressive Atypical Teratoid Rhabdoid Tumor (ATRT)

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This is a multi-treatment arm study that will be conducted through the Pacific Pediatric Neuro-oncology Consortium (PNOC).The study will assess the safety and efficacy of novel therapies and combinatorial strategies for participants with recurrent or progressive ATRT.
Protocol Amendment History 1 change
critical Recruitment opened 2026-06-24
Trial Details
NCT Number NCT07447076
Lead Sponsor Sabine Mueller, MD, PhD
Collaborators: Pacific Pediatric Neuro-Oncology Consortium, Rally Foundation
Conditions Recurrent Atypical Teratoid/Rhabdoid Tumor, Atypical Teratoid/Rhabdoid Tumor (ATRT) of the CNS
Enrollment 29 participants
Start Date 2026-06-17
Primary Completion 2035-12-31 (estimated)
Study Completion 2036-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-23